Ken Fisher, a successful multi-million dollar investor, emphasizes the importance of patience in the current bull market that appears to be slowing. Despite the current volatility, Fisher argues that this is a common feature in all bull markets, and investors should remain calm and not get carried away by fear.
According to him, the bull market that began last year still has potential and offers investment opportunities, but it requires patience to reap profits sporadically.
With decades of success in the investment world, and a net worth of $7.1 billion, Fisher stands behind his advice. It is noted that the analyst has certain stocks in his portfolio that exceed $1 billion in value, and many of the other specialists are also highly confident in these investments, calling them “strong buys.”
Investors interested in pursuing his strategy may want to consider doing more research on these stocks to take advantage of opportunities when the market rallies again.
Charles Schwab Corp.
Charles Schwab is the world’s leading online investment and financial services brokerage firm, founded by Charles R. Schwab in 1971. Over the years, it has become one of the leading financial institutions in the United States, offering a wide range of services, including stock and bond trading, mutual funds, and retirement accounts.
In early 2023, the company experienced a decline in its stock value due to the aftermath of major bank failures but has since recovered.
Despite a year-over-year decline in revenue, Charles Schwab beat Wall Street expectations in the second quarter. Fisher took advantage of the stock decline to acquire an additional 1,302,697 shares in the second quarter, increasing his stake in the company by 8%. He currently owns more than 18 million shares of Charles Schwab stock, worth approximately $1.04 billion.
Analysts, including Piper Sandler’s Patrick Moley, have a positive outlook on the company’s future, highlighting growth opportunities as interest rates rise. Moley rates Schwab’s stock a “Buy” and sets a price target of $86, representing 49% upside potential over the next year.
Most analysts support this view, with a consensus rating of “Strong Buy” and a median target suggesting a 28% increase in share value over the next 12 months.
The company has experienced a 30.5% decline since the beginning of the year and is approaching its third consecutive day of losses, sitting near its 100-day moving average, which has historically been an attractive entry point for bulls, with a history of 83% upside in the stock one month after reaching this trendline.
In addition, the put/call option volume ratio is at high levels, which could indicate a potential reversal. Add to that, Schaeffer’s volatility index is above its yearly readings, suggesting opportunities in the options market. The company also has an example of substantial gains from vertical options strategies, highlighting the potential for significant profits in a short period.
Investor Fisher is showing its commitment to diversification by backing medical device company Intuitive Surgical, owning more than 4 million shares valued at more than $1.32 billion.
California-based Intuitive Surgical is known for its innovative robotic surgery platform called da Vinci, which has revolutionized minimally invasive surgery in a variety of medical specialties. In the latest quarter, the company experienced a 22% increase in da Vinci surgeries worldwide, resulting in financial results that exceeded expectations, with revenue of $1.76 billion and adjusted EPS of $1.42.
Analyst Adam Maeder of Piper Sandler points to an underappreciated opportunity in China for Intuitive Surgical, anticipating substantial growth in the coming years. He forecasts that the company’s revenue in China could more than double from $300 million in 2023 to $650 million in 2027 due to growing demand for Da Vinci systems in the nation.
Maeder backs a “Buy” rating for Intuitive Surgical’s stock, with a price target of $385, implying a 30% upside in the next year. Most analysts are also bullish on the company, with 12 “Buy” and 2 “Hold” ratings, and an average price target of $377.14, suggesting an upside potential of 27%.
Thus, it is safe to say that Intuitive Surgical, Inc. is a company that has been getting a lot of attention recently due to its performance in the stock market. In the past month, its shares have risen 0.4%, in contrast to a 1% change in the S&P 500 Composite Index and a 1.6% drop in its sector. The key to predicting its near-term performance lies in revisions to earnings estimates.
The company is expected to post an 18.5% increase in earnings per share for the current quarter and 18.8% for the current fiscal year, according to analyst consensus. Despite the stability in these estimates over the past month, the stock rating tool, Zacks Rank, places Intuitive Surgical, Inc. shares with a “Hold” stance, suggesting that future revisions could influence its near-term market price.
Both Charles Schwab and Intuitive Surgical are a couple of examples of companies that specialist Ken Fisher recommends keeping on the radar. The U.S. investor’s strategies reflect the importance of patience and diversification in today’s markets. His support for companies like these is based on sound fundamental analysis and long-term growth prospects.
Despite market volatility and fluctuations, Fisher reminds investors that opportunities remain for those who stay calm and follow a long-term strategy. His investments and the support of other analysts indicate that companies such as these can offer significant potential in the coming years.
However, the choice is yours. What do you think? Do you believe that success in the market is based on a combination of patience, diversification, and careful analysis of investment opportunities? Is there a better mix?
Stay up to date with the latest news of the financial world with our NewsFlight newsletter.
(Information in this post is for general informational purposes only. It cannot and should not be considered as suggestions or recommendations regarding investing or financial decisions.)